allodynia glp-1 glp 1 treatment Frontiers Understanding Allodynia: A Side Effect

PMCID: PMC9915969

The medication can be a valuable support tool, but building lasting habits is what truly drives success

For instance, in phase 2 trials of SEMA 2.4 g, a substantial reduction in placebo response was observed in composite endpoints of MASH and fibrosis

Key Differences Between Oral and Injectable GLP-1s 1

Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis was published in The BMJ in January 2024

Despite this relative decline, NAEs persisted as a substantial AE subset, maintaining notable absolute reporting frequencies during the final three observation years (20212024) (Fig